Technology Transfer

Strategies for Overcoming Common Challenges in Tech Transfer

November 04, 2024

The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.

Tech Transfer in the New World of New Modalities

October 28, 2024

Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.

Tech Transfer Considerations

October 14, 2024

Ahmed Youssef, senior manager, USP Process Development at Ascend, provides insight on tech transfer when developing and manufacturing emerging therapies and new modalities.

Genentech Enters an Approximately $2 Billion Deal to License Sangamo Therapeutics Technologies for Developing Neurodegenerative Disease Therapeutics

August 20, 2024

Genentech will have access to Sangamo’s capsid delivery platform and epigenetic regulation capabilities to develop genomic medicines for certain neurodegenerative diseases.

Lonza and Oxford Nanopore Partner on mRNA Analytics

February 02, 2024

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

Exploring Best Practice Tech Transfer Methods for CGTs

December 06, 2023

Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.

Best Practice Tech Transfer Methods for CGTs

November 02, 2023

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.

Cellares Expands Agreement with Bristol Myers Squibb for Second CAR-T Program

October 13, 2023

Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.

BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System

October 11, 2023

Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.

Communication is Key in Complex Tech Transfer

February 15, 2023

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.